Lifetime risk of depression: restricted to a minority or waiting for most?

Overview of attention for article published in British Journal of Psychiatry, January 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 12 news outlets
blogs: 1 blog
policy: 1 policy source

twitter: 3 X users
patent: 1 patent
guideline: 3 clinical guideline sources

Readers on

mendeley: 80 Mendeley

So far, Altmetric has seen 4 Guidelines that reference this research output.

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines

Clinical guideline published by British Association for Psychopharmacology (BAP) on 12 May 2015

The British Association for Psychopharmacology (BAP) focuses on advancing the field of psychopharmacology through evidence-based guidelines and consensus statements. They provide resources for professionals, including guidelines on various mental health topics, enhancing clinical decision-making.

European Psychiatric Association (EPA) guidance on prevention of mental disorders

Clinical guideline published by European Psychiatric Association (EPA) on 01 Feb 2012

The European Psychiatric Association (EPA) is a leading organization representing psychiatry across Europe, focusing on improving mental health care and professional standards. It offers resources, training, and advocacy for psychiatrists, fostering collaboration and research in the field.

Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical Guidelines for the Management of Major Depressive Disorder in Adults. I. Classification, Burden and Principles of Management

Clinical guideline published by Canadian Network for Mood and Anxiety Treatments (CANMAT) on 12 Aug 2009

The Canadian Network for Mood and Anxiety Treatments (CANMAT) is a collaborative group of experts focused on enhancing clinical care for mood and anxiety disorders. They provide current treatment guidelines, educational resources for health professionals, and accessible information for patients and families.

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines

Clinical guideline published by British Association for Psychopharmacology (BAP) on 15 Apr 2008

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity.